Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen W Boucher

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 14, 2010
Challenges in anti-infective development in the era of bad bugs, no drugs: a regulatory perspective using the example of bloodstream infection as an indicationHelen W Boucher
Transactions of the American Clinical and Climatological Association|July 18, 2020
BAD BUGS, NO DRUGS 2002-2020: PROGRESS, CHALLENGES, AND CALL TO ACTIONHelen W Boucher
Infectious Disease Clinics of North America|August 25, 2014
A tribute to Dr Robert C. Moellering Jr (1937-2014)Helen W Boucher
The New England Journal of Medicine|January 31, 2019
Partial Oral Therapy for Osteomyelitis and Endocarditis - Is It Time?Helen W Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2008
Is it possible to blind a trial for community-acquired pneumonia?Helen W Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2007
Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureusHelen W Boucher, George Sakoulas
Expert Opinion on Pharmacotherapy|August 5, 2015
Dalbavancin for the treatment of acute bacterial skin and skin structure infectionsSheena Ramdeen, Helen W Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 24, 2011
Daptomycin for methicillin-resistant Staphylococcus aureus bloodstream infection and elevated vancomycin minimum inhibitory concentrations: has the time come?Adam Weston, Helen W Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 28, 2014
Editorial commentary: imminent challenges: carbapenem-resistant enterobacteriaceae in transplant recipients and patients with hematologic malignancyKatherine Johnson, Helen W Boucher
Open Forum Infectious Diseases|May 1, 2020
What's Hot in Clinical Infectious Diseases? 2019 IDWeek SummarySean Moss, Helen W Boucher
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 14, 2010
Challenges in anti-infective development in the era of bad bugs, no drugs: a regulatory perspective using the example of bloodstream infection as an indicationHelen W Boucher
Transactions of the American Clinical and Climatological Association|July 18, 2020
BAD BUGS, NO DRUGS 2002-2020: PROGRESS, CHALLENGES, AND CALL TO ACTIONHelen W Boucher
Infectious Disease Clinics of North America|August 25, 2014
A tribute to Dr Robert C. Moellering Jr (1937-2014)Helen W Boucher
The New England Journal of Medicine|January 31, 2019
Partial Oral Therapy for Osteomyelitis and Endocarditis - Is It Time?Helen W Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 18, 2008
Is it possible to blind a trial for community-acquired pneumonia?Helen W Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 9, 2007
Perspectives on Daptomycin resistance, with emphasis on resistance in Staphylococcus aureusHelen W Boucher, George Sakoulas
Expert Opinion on Pharmacotherapy|August 5, 2015
Dalbavancin for the treatment of acute bacterial skin and skin structure infectionsSheena Ramdeen, Helen W Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 24, 2011
Daptomycin for methicillin-resistant Staphylococcus aureus bloodstream infection and elevated vancomycin minimum inhibitory concentrations: has the time come?Adam Weston, Helen W Boucher
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 28, 2014
Editorial commentary: imminent challenges: carbapenem-resistant enterobacteriaceae in transplant recipients and patients with hematologic malignancyKatherine Johnson, Helen W Boucher
Open Forum Infectious Diseases|May 1, 2020
What's Hot in Clinical Infectious Diseases? 2019 IDWeek SummarySean Moss, Helen W Boucher
Pageof 9